First American Financial Corporation (FAF)

Revance Therapeutics Revenue

First American Financial had revenue of $1.84B in the quarter ending June 30, 2025, with 14.20% growth. This brings the company's revenue in the last twelve months to $6.51B, up 9.54% year-over-year. In the year 2024, First American Financial had annual revenue of $6.13B with 2.08% growth.

• Revenue (ttm): $6.51B
• Revenue Growth: +9.54%
• P/S Ratio: 0.97
• Revenue / Employee: $339,136
• Employees: 19,210
• Market Cap: 6.18B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.13B	124.60M	2.08%
Dec 31, 2023	6.00B	-1.60B	-21.06%
Dec 31, 2022	7.61B	-1.62B	-17.52%
Dec 31, 2021	9.22B	2.13B	30.13%
Dec 31, 2020	7.09B	884.00M	14.25%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.